{"id":"https://openalex.org/W1454056471","doi":null,"title":"Paclitaxel-ifosfamide-cisplatin as salvage chemotherapy in ovarian cancer patients pretreated with platinum compounds and paclitaxel.","display_name":"Paclitaxel-ifosfamide-cisplatin as salvage chemotherapy in ovarian cancer patients pretreated with platinum compounds and paclitaxel.","publication_year":2007,"publication_date":"2007-05-01","ids":{"openalex":"https://openalex.org/W1454056471","mag":"1454056471","pmid":"https://pubmed.ncbi.nlm.nih.gov/17595790"},"language":"en","primary_location":{"id":"pmid:17595790","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17595790","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Clinical Trial, Phase II"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111748606","display_name":"Aristides Polyzos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114623","display_name":"Laiko General Hospital of Athens","ror":"https://ror.org/02dvs1389","country_code":"GR","type":"healthcare","lineage":["https://openalex.org/I4210114623"]}],"countries":["GR"],"is_corresponding":false,"raw_author_name":"Aristides Polyzos","raw_affiliation_strings":["Medical Oncology Unit, Laiko General Hospital, Athens University School of Medicine, Athens, Greece. panoraiap@med.uoa.gr"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Unit, Laiko General Hospital, Athens University School of Medicine, Athens, Greece. panoraiap@med.uoa.gr","institution_ids":["https://openalex.org/I4210114623"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072956257","display_name":"Christos Kosmas","orcid":"https://orcid.org/0000-0001-6790-5785","observed_orcids":["https://orcid.org/0000-0001-6790-5785"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christos Kosmas","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110271146","display_name":"Nikolas B. Tsavaris","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nikolas Tsavaris","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003391473","display_name":"Helen Toufexi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Helen Toufexi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029472149","display_name":"Antonios Lagadas","orcid":"https://orcid.org/0009-0009-0615-3597","observed_orcids":["https://orcid.org/0009-0009-0615-3597"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Antonios Lagadas","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090633646","display_name":"Helen J Gogas","orcid":"https://orcid.org/0000-0002-0451-2885","observed_orcids":["https://orcid.org/0000-0002-0451-2885"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Helen Gogas","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110812175","display_name":"Kostas Giannakopoulos","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kostas Giannakopoulos","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017462015","display_name":"Gregory P. Kouraklis","orcid":"https://orcid.org/0000-0001-9092-5346","observed_orcids":["https://orcid.org/0000-0001-9092-5346"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gregory Kouraklis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033556587","display_name":"John Gr\u0131n\u0131atsos","orcid":"https://orcid.org/0000-0001-8801-7015","observed_orcids":["https://orcid.org/0000-0001-8801-7015"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John Griniatsos","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108350655","display_name":"E. Felekouras","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Evagelos Felekouras","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065339449","display_name":"Christos Tsigris","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christos Tsigris","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041448475","display_name":"Nikolas Nikiteas","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nikolas Nikiteas","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108453872","display_name":"Othon N. Papadopoulos","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Othon Papadopoulos","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5087643777","display_name":"Athanasios G. Giannopoulos","orcid":"https://orcid.org/0000-0002-6494-0224","observed_orcids":["https://orcid.org/0000-0002-6494-0224"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Athanasios Giannopoulos","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.5362,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.68932039,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"27","issue":"3B","first_page":"1645","last_page":"51"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10668","display_name":"Endometrial and Cervical Cancer Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2729","display_name":"Obstetrics and Gynecology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.902999997138977},{"id":"https://openalex.org/keywords/salvage-chemotherapy","display_name":"salvage chemotherapy","score":0.8880000114440918},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.9589999914169312},{"id":"https://openalex.org/keywords/ifosfamide","display_name":"ifosfamide","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/platinum-resistance","display_name":"platinum resistance","score":0.8939999938011169},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.5289999842643738},{"id":"https://openalex.org/keywords/myelosuppression","display_name":"myelosuppression","score":0.6830000281333923},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.7870000004768372},{"id":"https://openalex.org/keywords/granulocyte-colony-stimulating-factor","display_name":"granulocyte colony-stimulating factor","score":0.8389999866485596},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.5680000185966492},{"id":"https://openalex.org/keywords/response-rate","display_name":"response rate","score":0.7210000157356262},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.37400001287460327},{"id":"https://openalex.org/keywords/dose-intensity","display_name":"dose intensity","score":0.3659999966621399}],"concepts":[{"id":"https://openalex.org/C2777506904","wikidata":"https://www.wikidata.org/wiki/Q418560","display_name":"Ifosfamide","level":4,"score":0.932145893573761},{"id":"https://openalex.org/C2780376820","wikidata":"https://www.wikidata.org/wiki/Q424997","display_name":"Mesna","level":5,"score":0.840201735496521},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.7649974226951599},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7530226111412048},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.7303326725959778},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5936978459358215},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.5582665205001831},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.5294525027275085},{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.49715498089790344},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.47904860973358154},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4646247327327728},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.44407573342323303},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4129783809185028},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.408661812543869},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.40462368726730347},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3887721300125122},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3398834764957428}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007069","descriptor_name":"Ifosfamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007069","descriptor_name":"Ifosfamide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016879","descriptor_name":"Salvage Therapy","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016879","descriptor_name":"Salvage Therapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D017671","descriptor_name":"Platinum Compounds","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:17595790","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17595790","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Clinical Trial, Phase II"},{"id":"mag:1454056471","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17595790","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W143234260","https://openalex.org/W1554317310","https://openalex.org/W1892271037","https://openalex.org/W1983418415","https://openalex.org/W1985900467","https://openalex.org/W2017886436","https://openalex.org/W2026831303","https://openalex.org/W2029409133","https://openalex.org/W2029490718","https://openalex.org/W2056629171","https://openalex.org/W2093749063","https://openalex.org/W2094678953","https://openalex.org/W2097105130","https://openalex.org/W2102551452","https://openalex.org/W2110020593","https://openalex.org/W2110357914","https://openalex.org/W2117729836","https://openalex.org/W2120530458","https://openalex.org/W2155126523","https://openalex.org/W2165862201","https://openalex.org/W2167805334","https://openalex.org/W2260083111","https://openalex.org/W2328421677","https://openalex.org/W2398799880","https://openalex.org/W2399496714","https://openalex.org/W2411304567","https://openalex.org/W2426893197","https://openalex.org/W2437504105","https://openalex.org/W2468488790"],"related_works":["https://openalex.org/W2121631526","https://openalex.org/W2085586686","https://openalex.org/W2309555766","https://openalex.org/W2270672625","https://openalex.org/W2153874783","https://openalex.org/W1985900467","https://openalex.org/W2993264568","https://openalex.org/W2004715659","https://openalex.org/W2094678953","https://openalex.org/W2141505363"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1,28,85,264,372],"role":[2],"of":[3,10,38,46,117,177,185,197,223,249,307,313,316,348,392,398,405],"combination":[4,41,68,356],"chemotherapy":[5],"regimens":[6],"in":[7,42,50,53,82,233,239,251,255,260,303,343,361,369,402],"the":[8,34,43,49,83,91,191,198,202,274,285,353,393,399],"management":[9],"ovarian":[11],"cancer":[12],"patients":[13,79,110,208],"with":[14,155,190,219,296,324,378],"tumors":[15,364],"previously":[16],"exposed":[17],"to":[18,73,277,388],"platinum":[19,100],"compounds":[20],"and":[21,36,52,90,107,141,143,212,236,258,284,300,305,321,329,338,346,365],"paclitaxel":[22,118],"has":[23],"not":[24],"yet":[25],"been":[26],"defined.":[27],"present":[29,394],"phase":[30],"II":[31],"study":[32],"evaluated":[33],"activity":[35],"toxicity":[37],"a":[39,65,122,175,220,246,358,366],"paclitaxel-ifosfamide-cisplatin":[40],"aforementioned":[44],"group":[45,404],"patients.":[47,242,406],"Given":[48],"vitro":[51],"vivo":[54],"synergism":[55],"between":[56],"these":[57],"three":[58,66,203,354,400],"agents,":[59],"it":[60],"was":[61,88,172,231,268,294],"believed":[62],"that":[63],"using":[64],"drug":[67,355],"would":[69],"overcome":[70],"tumor":[71],"resistance":[72],"cisplatin.":[74],"PATIENTS":[75],"AND":[76],"METHODS:":[77],"Thirty-five":[78],"were":[80,159,188,215,319],"enrolled":[81],"study.":[84],"median":[86,92,184,265,275,286],"age":[87],"55":[89],"performance":[93],"status":[94],"1.":[95],"Thirteen":[96],"(37%)":[97],"had":[98,104,111],"potentially":[99,252,362],"sensitive,":[101],"12":[102,288],"(35%)":[103],"primary":[105,256],"platinum-resistant":[106,113,257,262,370],"10":[108,216],"(28%)":[109],"secondary":[112,261],"tumors.":[114,263,371],"Treatment":[115],"consisted":[116],"175":[119],"mg/m2":[120,132,146],"as":[121],"3":[123,162,299,339],"h":[124,136,150],"i.v.":[125,133,147,327],"infusion":[126],"on":[127,152,164,180],"day":[128],"1,":[129,336],"cisplatin":[130],"75":[131],"over":[134,138,148,396],"2":[135,337],"fractionated":[137,151],"days":[139,153,181],"1":[140,149],"2,":[142],"ifosfamide":[144],"5":[145,178,269],"1-2":[154],"mesna":[156],"uroprotection.":[157],"Courses":[158],"administered":[160,189],"every":[161],"weeks":[163],"an":[165],"outpatient":[166],"basis.":[167],"Granulocyte-colony":[168],"stimulation":[169],"factor":[170],"(G-CSF)":[171],"given":[173],"at":[174,195],"dose":[176,193,200],"microg/kg/day":[179],"4-10.":[182],"A":[183],"4":[186,301],"cycles":[187],"delivered":[192],"intensity":[194],"85%":[196],"planned":[199],"for":[201,210],"agents.":[204],"RESULTS:":[205],"Among":[206],"35":[207],"evaluable":[209],"response":[211,221,247,266],"toxicity,":[213],"there":[214],"partial":[217],"responses":[218],"rate":[222,248],"28.6%":[224],"(95%":[225],"confidence":[226],"interval":[227],"12%-45%).":[228],"Stable":[229],"disease":[230,238],"recorded":[232],"9":[234],"(25.7%)":[235],"progressive":[237],"16":[240],"(45.7%)":[241],"Subgroup":[243],"analysis":[244],"revealed":[245],"38.5%":[250],"platinum-sensitive,":[253],"16.5%":[254],"30%":[259,345],"duration":[267],"months":[270,280,289],"(range":[271,281,290],"3-14":[272],"months),":[273],"time":[276],"progression":[278],"6":[279],"3-18":[282],"months)":[283],"survival":[287],"3-44":[291],"months).":[292],"Myelotoxicity":[293],"significant":[295,359],"neutropenia":[297,318],"grade":[298],"occurring":[302],"35%":[304],"45%":[306],"patients,":[308,349],"respectively.":[309,350],"Eight":[310],"episodes":[311],"(5%":[312],"all":[314],"cycles)":[315],"febrile":[317],"documented":[320],"well":[322],"managed":[323],"oral":[325],"or":[326],"antibiotics":[328],"G-CSF":[330,379],"continuation":[331],"until":[332],"complete":[333],"recovery.":[334],"Grade":[335],"peripheral":[340],"neuropathy":[341],"developed":[342],"30%,":[344],"10%":[347],"In":[351],"conclusion,":[352],"demonstrated":[357],"effectiveness":[360],"platinum-sensitive":[363],"moderate":[367],"efficacy":[368],"regimen,":[373],"although":[374],"myelotoxic,":[375],"is":[376,386],"tolerable":[377],"support.":[380],"Further":[381],"investigation":[382],"via":[383],"comparative":[384],"studies":[385],"required":[387],"define":[389],"any":[390],"superiority":[391],"regimen":[395],"doublets":[397],"agents":[401],"this":[403]},"counts_by_year":[{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}